$GUER
Guerrilla RF Inc Stock $guer

$guer Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000143774924010107 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$5.091M	$4.702M	$15.08M
YoY Change	57.58%	93.64%	29.98%
Cost Of Revenue	$1.871M	$2.029M	$6.473M
YoY Change	33.3%	91.5%	33.87%
Gross Profit	$3.221M	$2.673M	$8.605M
YoY Change	76.22%	95.29%	27.19%
Gross Profit Margin	63.26%	56.84%	57.07%
Selling, General & Admin	$2.808M	$2.504M	$11.25M
YoY Change	-3.46%	0.34%	15.09%
% of Gross Profit	87.18%	93.71%	130.7%
Research & Development	$2.252M	$2.268M	$10.28M
YoY Change	-12.94%	3.18%	26.72%
% of Gross Profit	69.91%	84.86%	119.5%
Depreciation & Amortization	$366.3K	$348.2K	$1.593M
YoY Change	-8.04%	-23.8%	17.31%
% of Gross Profit	11.37%	13.03%	18.51%
Operating Expenses	$5.059M	$4.773M	$21.53M
YoY Change	-7.92%	1.67%	20.36%
Operating Profit	-$1.839M	-$2.100M	-$12.92M
YoY Change	-49.86%	-36.86%	16.21%
Interest Expense	-$1.685M	-$1.537M	-$2.904M
YoY Change	392.83%	246.69%	232.05%
% of Operating Profit
Other Income/Expense, Net	-$1.534M	-$26.26K	-$3.042M
YoY Change	358.34%	-247.94%	236.01%
Pretax Income		-$3.663M	-$15.97M
YoY Change		-2.35%	32.76%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$3.400M	-$3.663M	-$16.00M
YoY Change	-15.0%	-2.35%	33.33%
Net Earnings / Revenue	-66.78%	-77.9%	-106.11%
Basic Earnings Per Share	-$0.42		-$2.25
Diluted Earnings Per Share		-$0.46	-$2.25
COMMON SHARES
Basic Shares Outstanding	7.937M	7.890M	7.106M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$781.3K	$781.3K
YoY Change		-82.0%	-82.0%
Cash & Equivalents	$3.601M	$781.3K	$781.3K
Short-Term Investments
Other Short-Term Assets		$458.3K	$458.3K
YoY Change		-28.77%	-28.77%
Inventory	$1.774M	$1.534M	$1.534M
Prepaid Expenses	$540.9K	$458.3K
Receivables	$2.820M	$2.079M	$2.079M
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$8.735M	$4.852M	$4.852M
YoY Change	49.89%	-37.64%	-37.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.333M	$3.659M	$14.16M
YoY Change	-33.13%	-28.23%	166.77%
Goodwill
YoY Change
Intangibles		$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Assets	$13.54M	$14.16M	$14.16M
YoY Change	-15.2%	59.41%	59.41%
TOTAL ASSETS
Total Short-Term Assets	$8.735M	$4.852M	$4.852M
Total Long-Term Assets	$13.54M	$14.16M	$14.16M
Total Assets	$22.28M	$19.01M	$19.01M
YoY Change	2.2%	14.09%	14.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$2.100M	$2.100M
YoY Change		-52.99%	-52.99%
Accrued Expenses		$746.0K	$746.0K
YoY Change		433.64%	433.64%
Deferred Revenue
YoY Change
Short-Term Debt		$1.629M	$1.629M
YoY Change		69.69%	69.69%
Long-Term Debt Due		$12.71M	$12.71M
YoY Change		1078.14%	1078.14%
Total Short-Term Liabilities	$8.102M	$17.34M	$17.34M
YoY Change	50.11%	160.96%	160.96%
LONG-TERM LIABILITIES
Long-Term Debt		$2.293M	$2.293M
YoY Change		-69.81%	-69.81%
Other Long-Term Liabilities		$6.177M	$6.177M
YoY Change		8513.18%	8513.18%
Total Long-Term Liabilities		$8.469M	$8.469M
YoY Change		10.49%	10.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.102M	$17.34M	$17.34M
Total Long-Term Liabilities		$8.469M	$8.469M
Total Liabilities	$26.30M	$25.81M	$25.81M
YoY Change	35.47%	80.35%	80.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$46.40M	-$43.00M
YoY Change	49.2%	58.67%
Common Stock	$995.00	$789.00
YoY Change	46.76%	-78.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.027M	-$6.796M	-$6.796M
YoY Change
Total Liabilities & Shareholders Equity	$22.28M	$19.01M	$19.01M
YoY Change	2.2%	14.09%	14.09%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$3.400M	-$3.663M	-$16.00M
YoY Change	-15.0%	-2.35%	33.33%
Depreciation, Depletion And Amortization	$366.3K	$348.2K	$1.593M
YoY Change	-8.04%	-23.8%	17.31%
Cash From Operating Activities	-$842.4K	-$2.276M	-$13.45M
YoY Change	-85.56%	-30.35%	46.25%
INVESTING ACTIVITIES
Capital Expenditures	$26.00K	-$36.76K	$101.7K
YoY Change	-77.93%	-96.47%	-81.5%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$26.00K	$36.76K	-$101.7K
YoY Change	-77.93%	-96.47%	-81.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.688M	2.144M	$9.998M
YoY Change	5.66%	-52.5%	13.29%
NET CHANGE
Cash From Operating Activities	-$842.4K	-2.276M	-$13.45M
Cash From Investing Activities	-$26.00K	36.76K	-$101.7K
Cash From Financing Activities	$3.688M	2.144M	$9.998M
Net Change In Cash	$2.819M	-95.58K	-$3.559M
YoY Change	-214.48%	-104.18%	265.57%
FREE CASH FLOW
Cash From Operating Activities	-$842.4K	-$2.276M	-$13.45M
Capital Expenditures	$26.00K	-$36.76K	$101.7K
Free Cash Flow	-$868.4K	-$2.239M	-$13.56M
YoY Change	-85.41%	0.51%	39.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7893205
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7893205
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6211206
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6211206
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	usd
CY2023Q4	guer	Common Stock Voting Rights Vote Per Share CommonStockVotingRightsVotePerShare	1	pure
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2600000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	300000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1459979	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1233668	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1056589	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1076140	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1096206	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4890149	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10812731	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3890254	usd
CY2023Q4	guer	Operating Lease Liability Year One OperatingLeaseLiabilityYearOne	745969	usd
CY2023Q4	guer	Operating Lease Liability Year Two OperatingLeaseLiabilityYearTwo	598454	usd
CY2023Q4	guer	Operating Lease Liability Year Three OperatingLeaseLiabilityYearThree	475769	usd
CY2023Q4	guer	Operating Lease Liability Year Four OperatingLeaseLiabilityYearFour	551585	usd
CY2023Q4	guer	Operating Lease Liability Year Five OperatingLeaseLiabilityYearFive	635273	usd
CY2023Q4	guer	Operating Lease Liability After Year Five OperatingLeaseLiabilityAfterYearFive	3915427	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6922477	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1135917	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	815150	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	722306	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	156861	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	49664	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	10702	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2890600	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	318078	usd
CY2023Q4	guer	Finance Lease Liability Year One FinanceLeaseLiabilityYearOne	976907	usd
CY2023Q4	guer	Finance Lease Liability Year Two FinanceLeaseLiabilityYearTwo	717538	usd
CY2023Q4	guer	Finance Lease Liability Year Three FinanceLeaseLiabilityYearThree	676037	usd
CY2023Q4	guer	Finance Lease Liability Year Four FinanceLeaseLiabilityYearFour	145605	usd
CY2023Q4	guer	Finance Lease Liability Year Five FinanceLeaseLiabilityYearFive	45877	usd
CY2023Q4	guer	Finance Lease Liability After Year Five FinanceLeaseLiabilityAfterYearFive	10558	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2572522	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56238
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3837067
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2000 Pisgah Church Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Greensboro
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27455
CY2023	dei	City Area Code CityAreaCode	336
CY2023	dei	Local Phone Number LocalPhoneNumber	510-7840
CY2023	dei	Security12g Title Security12gTitle	Common Stock, $0.0001 par value per share
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	37713020	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7937079
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2023Q4	us-gaap	Cash Cash	781318	usd
CY2022Q4	us-gaap	Cash Cash	4340407	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2079111	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1124971	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1533592	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672925	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	458313	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	643401	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4852334	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7781704	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	0	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	3574746	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10500620	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	209669	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	3659084	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	5098097	usd
CY2023Q4	us-gaap	Assets Assets	19012038	usd
CY2022Q4	us-gaap	Assets Assets	16664216	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2099537	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4426477	usd
CY2023Q4	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	1628667	usd
CY2022Q4	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	959803	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	158000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	745969	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	139794	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	978543	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1078506	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	10948668	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17338478	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6604580	usd
CY2023Q4	guer	Longterm Debt Noncurrent Excluding Longterm Notes Payable LongtermDebtNoncurrentExcludingLongtermNotesPayable	698600	usd
CY2022Q4	guer	Longterm Debt Noncurrent Excluding Longterm Notes Payable LongtermDebtNoncurrentExcludingLongtermNotesPayable	44279	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6176508	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	71714	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1593979	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2984618	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4604132	usd
CY2023Q4	us-gaap	Liabilities Liabilities	25807565	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14309323	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	789	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	621	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	36243146	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29427440	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43039462	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27073168	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6795527	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2354893	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19012038	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16664216	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15078316	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11600904	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6473477	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4835632	usd
CY2023	us-gaap	Gross Profit GrossProfit	8604839	usd
CY2022	us-gaap	Gross Profit GrossProfit	6765272	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10282635	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8114377	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5677141	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4634012	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5569654	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5138410	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	21529430	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	17886799	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-12924591	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-11121527	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2904454	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-874713	usd
CY2023	guer	Fair Value Adjustment Of Derivative Liabilities FairValueAdjustmentOfDerivativeLiabilities	142200	usd
CY2022	guer	Fair Value Adjustment Of Derivative Liabilities FairValueAdjustmentOfDerivativeLiabilities	-0	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4951	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-30526	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3041703	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-905239	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15966294	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12026766	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.25
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.17
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7105880
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5550373
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8915625	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12026766	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5232	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	52000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4765232	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	643570	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2354893	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15966294	usd
CY2023	guer	Stock Issued During Period Value Restricted Stock Award Settlement StockIssuedDuringPeriodValueRestrictedStockAwardSettlement	4320	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5440658	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1279536	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6795527	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15966294	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12026766	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1592567	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1357571	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1279536	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	643570	usd
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	407710	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	39568	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	1130731	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	48070	usd
CY2023	guer	Impairment Property Plant And Equipment And Operating Lease ImpairmentPropertyPlantAndEquipmentAndOperatingLease	115438	usd
CY2022	guer	Impairment Property Plant And Equipment And Operating Lease ImpairmentPropertyPlantAndEquipmentAndOperatingLease	0	usd
CY2023	guer	Fair Value Adjustment Of Derivative Liabilities FairValueAdjustmentOfDerivativeLiabilities	142200	usd
CY2022	guer	Fair Value Adjustment Of Derivative Liabilities FairValueAdjustmentOfDerivativeLiabilities	0	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	9661	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	954140	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-542035	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-129672	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	233911	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1125369	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-862375	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2366260	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	722380	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-101180	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1203295	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13454990	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9248403	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	101714	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	549850	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-101714	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-549850	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	16759886	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	9070726	usd
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	5440658	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	4765232	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5232	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	10590115	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	3977778	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1043149	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	985622	usd
CY2023	guer	Repayment Of Finance Insurance Premiums Financing Activities RepaymentOfFinanceInsurancePremiumsFinancingActivities	569665	usd
CY2022	guer	Repayment Of Finance Insurance Premiums Financing Activities RepaymentOfFinanceInsurancePremiumsFinancingActivities	53115	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9997615	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8824675	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3559089	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-973578	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4340407	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5313985	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	781318	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4340407	usd
CY2023	guer	Modification On Operating And Finance Leases ModificationOnOperatingAndFinanceLeases	806617	usd
CY2022	guer	Modification On Operating And Finance Leases ModificationOnOperatingAndFinanceLeases	0	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	100000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	271725	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	4745311	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	35000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	15873	usd
CY2023	guer	Financing Of Property And Equipment FinancingOfPropertyAndEquipment	483787	usd
CY2022	guer	Financing Of Property And Equipment FinancingOfPropertyAndEquipment	0	usd
CY2023	guer	Financing Of Insurance Premium And Software FinancingOfInsurancePremiumAndSoftware	470860	usd
CY2022	guer	Financing Of Insurance Premium And Software FinancingOfInsurancePremiumAndSoftware	382843	usd
CY2023	guer	Financing Of Mask Set FinancingOfMaskSet	369421	usd
CY2022	guer	Financing Of Mask Set FinancingOfMaskSet	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7837471	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	327400	usd
CY2023	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	52000	usd
CY2023	guer	Other Longterm Asset Additions Included In Accounts Payable OtherLongtermAssetAdditionsIncludedInAccountsPayable	0	usd
CY2022	guer	Other Longterm Asset Additions Included In Accounts Payable OtherLongtermAssetAdditionsIncludedInAccountsPayable	2369612	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="margin: 0pt; font-size: 10pt; font-family: "Times New Roman";"><b><em style="font: inherit;">1.</em> Organization and Nature of Business</b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Guerrilla RF, Inc. (formerly known as Laffin Acquisition Corp., the “Company”) was incorporated in the State of Delaware on <em style="font: inherit;"> November 9, 2020. </em>On <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021,</em> the Company's wholly-owned subsidiary, Guerrilla RF Acquisition Corp., a corporation formed in the State of Delaware on <em style="font: inherit;"> October </em><em style="font: inherit;">20,</em> <em style="font: inherit;">2021</em> (“Acquisition Sub”) and privately held Guerrilla RF Operating Corporation (formerly known as Guerrilla RF, Inc.) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, on <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021</em> (the “Closing Date”), Acquisition Sub merged with and into Guerrilla RF Operating Corporation with Guerrilla RF Operating Corporation continuing as the surviving corporation and a wholly-owned subsidiary of the Company (the “Merger”). On <em style="font: inherit;"> May 30, 2023, </em>Guerrilla RF Operating Corporation was merged with and into Guerrilla RF, Inc. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Prior to the Merger, Laffin Acquisition Corp. was a “shell” company registered under the Exchange Act, with <em style="font: inherit;">no</em> specific business plan or purpose until it began operating the business of Guerrilla RF Operating Corporation following the closing of the Merger.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">All references in these Consolidated Financial Statements to “Guerrilla RF” refer to: (i) for periods prior to <em style="font: inherit;"> May 30, 2023, </em>Guerrilla RF Operating Corporation; and (ii) for subsequent periods, Guerrilla RF, Inc. Unless otherwise stated or the context otherwise indicates, references to the “Company”, “we”, “our”, “us” or similar terms refer to Guerrilla RF, Inc. together with Guerrilla RF Operating Corporation.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Guerrilla RF designs and manufactures high‐performance Monolithic Microwave Integrated Circuits (MMICs) for the wireless infrastructure market. Guerrilla RF primarily focuses on researching and developing its existing products and building an infrastructure to handle a global distribution network; therefore, it has incurred significant start‐up losses. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><span style="background-color:#ffffff;">Liquidity and Going Concern</span></b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><span style="background-color:#ffffff;">In accordance with Financial Accounting Standards Accounting Standards Update (“ASU”) </span><i><span style="background-color:#ffffff;"><em style="font: inherit;">No.</em></span></i><span style="background-color:#ffffff;"> </span><i><span style="background-color:#ffffff;"><em style="font: inherit;">2014</em></span></i><span style="background-color:#ffffff;">-</span><i><span style="background-color:#ffffff;"><em style="font: inherit;">15,</em> Disclosure of Uncertainties about an Entity</span></i><span style="background-color:#ffffff;">’</span><i><span style="background-color:#ffffff;">s Ability to Continue as a Going Concern (Subtopic</span></i><span style="background-color:#ffffff;"> </span><i><span style="background-color:#ffffff;"><em style="font: inherit;">205</em>-<em style="font: inherit;">40</em>)</span></i><span style="background-color:#ffffff;">, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within <em style="font: inherit;">one</em> year after the date that the consolidated financial statements are issued. The accompanying consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the ordinary course of business. The Company has historically financed its activities through a combination of commercial loans and the proceeds of debt and equity issuances. The consolidated financial statements do <em style="font: inherit;">not</em> include any adjustments relating to the recoverability of the recorded assets or the classification of liabilities that <em style="font: inherit;"> may </em>be necessary should the Company be unable to continue as a going concern.</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Company has incurred substantial negative cash flows from operations in nearly every fiscal period since inception. For the year ended </span><em style="font: inherit;"> December 31, 2023</em><span style="background-color:#ffffff;">, the Company incurred a net loss of $16.0 million and used $13.4 million in cash to fund operations. As a result, the Company had an accumulated deficit of $43.0 million as of </span><em style="font: inherit;"> December 31, 2023</em><span style="background-color:#ffffff;">. The Company's cash as of </span><em style="font: inherit;"> December 31, 2023</em><span style="background-color:#ffffff;"> was $0.8 million. We expect losses and negative cash flows to continue in the near term, primarily due to continued investment in research and development, sales and marketing efforts, and increased administration expenses as our Company grows. We plan to continue to invest in the implementation of our long-term strategic plan and we anticipate that we will require additional funding in fiscal <em style="font: inherit;">2024.</em> There is <em style="font: inherit;">no</em> assurance that appropriate funding will be available on terms, which are acceptable to us, or at all. This requirement for additional funding raises substantial doubt about our ability to continue as a going concern.</span></p> <p style="text-align: justify; font-size: 10pt; font-family: "Times New Roman"; margin: 0pt;"><span style="background-color:#ffffff;"> </span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">Our primary source of liquidity has been from cash raised from private placements and debt financing. We also have <em style="font: inherit;">two</em> loan facilities, <em style="font: inherit;">one</em> of which is for up to $3.0 million with a specialty lender (referred to as the Spectrum Loan Facility, described in Note <em style="font: inherit;">5</em> to our consolidated financial statements), and the other for $12.0 million with a different lender (referred to as the Salem Loan Facility, also described in Note <em style="font: inherit;">5</em> to our consolidated financial statements). As of </span><em style="font: inherit;"> December 31, 2023</em><span style="background-color:#ffffff;">, we had drawn down $1.2 million under the Spectrum Loan Facility and the full $12.0 million under the Salem Loan Facility. On <em style="font: inherit;"> March 28, 2024 </em>we completed a private placement offering of approximately $5 million, raising net cash proceeds of approximately $3 million, after deduction of expenses and the conversion of existing debt. In addition, Salem extended the maturity date of the Salem Loan Facility from <em style="font: inherit;"> April 30, 2024 </em>to <em style="font: inherit;"> January 31, 2026. </em>As a result, the Company believes that its existing cash and cash equivalents will provide sufficient resources to support operations for the rest of this fiscal year and beyond. Nevertheless, with the variability of results each quarter and other risks associated with its business, the Company recognizes that liquidity could become an issue and recognizes that it <em style="font: inherit;"> may </em>require additional funding at some time in the next <em style="font: inherit;">12</em> months. The Company <em style="font: inherit;"> may </em>also require additional funds to respond to business challenges, including developing new solutions or enhancing existing solutions, enhancing our operating infrastructure, expanding our sales and marketing capabilities, and acquiring complementary businesses, technologies, or assets. The Company recognizes that it <em style="font: inherit;"> may </em>be unable to secure additional funding sources at rates and terms acceptable or at all, and as a result there is substantial doubt about our ability to continue as a going concern.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b></b></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Risks and Uncertainties</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company is subject to several risks associated with companies at a similar stage, including dependence on key individuals, competition from similar products and larger companies, volatility of the industry, ability to obtain adequate financing to support growth, the ability to attract and retain additional qualified personnel to manage the anticipated growth of the Company, and general economic conditions including the current macro-economic conditions impacting the banking and financial markets. </p>
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-16000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43000000	usd
CY2023Q4	us-gaap	Cash Cash	800000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and reported amounts of revenue and expenses during the reporting period. In addition, the Company’s significant estimates and judgments involve the valuation of share-based compensation and the evaluation of equity financing, including the<span style="background-color:#ffffff;"> underlying fair value of the common stock. According</span>ly, actual results could differ from those estimates.</p>
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Reclassifications</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Certain prior period income statement and balance sheets amounts have been reclassified to conform to the Company's fiscal <em style="font: inherit;">2023</em> presentation. The reclassifications have <em style="font: inherit;">no</em> impact on the Company's previously reported net loss. </p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Concentrations of Credit Risk and Major Customers</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Financial instruments at <span style="background-color:#ffffff"><em style="font: inherit;"> December 31, 2023</em></span><span style="color:#000000;"> and </span><span style="color:#000000;"><em style="font: inherit;">2022</em></span><span style="color:#000000;"> </span>that potentially subject the Company to concentration of credit risk consist primarily of cash and accounts receivable. The Company’s cash is deposited with major financial institutions in the U.S. At times, deposits in financial institutions located in the U.S. <em style="font: inherit;"> may </em>be in excess of the amount of insurance provided on such deposits by the Federal Deposit Insurance Corporation (FDIC). To date, the Company has <em style="font: inherit;">not</em> experienced any losses on its cash deposits.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b></b></p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><span style="background-color:#ffffff;">The Company’s accounts receivable are derived from revenue earned from customers located in and outside of the U.S. Major customers are defined as those generating revenue in excess of <em style="font: inherit;">10%</em> of the Company’s annual product shipment revenue. The Company had <span style="-sec-ix-hidden:c109736759"><span style="-sec-ix-hidden:c109736760">one</span></span> major customer during the years ended </span><em style="font: inherit;"> December 31, 2023</em><span style="color:#000000"><span style="background-color:#ffffff;"> and </span></span><em style="font: inherit;">2022</em><span style="background-color:#ffffff;">. Revenues from the major customer accounted for 81% of product shipment revenue for both the years ended </span><em style="font: inherit;"> December 31, 2023</em><span style="color:#000000"><span style="background-color:#ffffff;"> and </span></span><em style="font: inherit;">2022</em><span style="background-color:#ffffff;">. Accounts receivable from our major customer represented 71% of accounts receivable at </span><em style="font: inherit;"> December 31, 2023</em><span style="background-color:#ffffff;">, and 76% of accounts receivable at </span><em style="font: inherit;"> December 31, 2022</em><span style="color:#000000;"><span style="background-color:#ffffff;">.</span></span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q2	guer	Factoring Agreement Advance Amount Percentage Of Accounts Receivable FactoringAgreementAdvanceAmountPercentageOfAccountsReceivable	0.85	pure
	guer	Factoring Agreement Receivables Term Oustanding FactoringAgreementReceivablesTermOustanding	P90D
CY2022Q2	guer	Factoring Agreement Percentage Of Receivables Collateral FactoringAgreementPercentageOfReceivablesCollateral	0.15	pure
CY2023	guer	Contract With Customer Liability Revenue To Be Recognized ContractWithCustomerLiabilityRevenueToBeRecognized	250000	usd
CY2022	guer	Contract With Customer Liability Revenue To Be Recognized ContractWithCustomerLiabilityRevenueToBeRecognized	0	usd
CY2023	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	19961	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	39219	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1849730
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1222738
CY2023	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	6	pure
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	488548	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	696409	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	132511	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	44037	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	922194	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	932479	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	9661	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	-0	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1533592	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672925	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	9661	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4352104	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2900932	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3659084	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5098097	usd
CY2023	us-gaap	Depreciation Depreciation	1592567	usd
CY2022	us-gaap	Depreciation Depreciation	1357571	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	20000	usd
CY2023Q4	guer	Factoring Agreement Advance Amount Percentage Of Accounts Receivable FactoringAgreementAdvanceAmountPercentageOfAccountsReceivable	0.85	pure
CY2023Q4	guer	Factoring Agreement Factoring Fee First Thirty Days Percentage Of Invoice Face Value FactoringAgreementFactoringFeeFirstThirtyDaysPercentageOfInvoiceFaceValue	0.0098	pure
CY2023Q4	guer	Factoring Agreement Factoring Fee After Thirty Days Percentage Of Invoice Face Value FactoringAgreementFactoringFeeAfterThirtyDaysPercentageOfInvoiceFaceValue	0.000327	pure
CY2023Q4	guer	Factoring Agreement Minimum Invoice Fee FactoringAgreementMinimumInvoiceFee	1.5	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	13356429	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	230372	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	236384	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	192319	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	39525	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	14055029	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5524534
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	11500000	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2100000	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	94667
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	210000
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	4.2
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	9.42
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.52	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.52	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0388	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0396	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.61
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.8
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	344275	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	530147
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.28
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M13D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	78667
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	13.47
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2117
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.46
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5477
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.7
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	601220
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.6
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y11M15D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	13135
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.67
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	43607
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.62
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	570748
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.67
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y11M23D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	503778
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.69
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M17D
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1279536	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	643570	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	usd
CY2023	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	158000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2600000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	300000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10500620	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	745969	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6176508	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6922477	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2528643	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	978543	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1593979	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2572522	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1651539	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	135842	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1205155	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	977771	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	246053	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	251228	usd
CY2023	guer	Finance Lease Cost FinanceLeaseCost	1451208	usd
CY2022	guer	Finance Lease Cost FinanceLeaseCost	1228999	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y8M4D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y11M23D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.11	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0756	pure
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1726941	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	243865	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1043149	usd
CY2023Q4	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year One LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearOne	714010	usd
CY2023Q4	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Two LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearTwo	635214	usd
CY2023Q4	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Three LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearThree	580820	usd
CY2023Q4	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Four LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearFour	524555	usd
CY2023Q4	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Five LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearFive	460933	usd
CY2023Q4	guer	Lessee Operating Lease Liability Undiscounted Excess Amount After Year Five LesseeOperatingLeaseLiabilityUndiscountedExcessAmountAfterYearFive	974722	usd
CY2023Q4	guer	Finance Lease Liability Undiscounted Excess Amount Next Twelve Months FinanceLeaseLiabilityUndiscountedExcessAmountNextTwelveMonths	159010	usd
CY2023Q4	guer	Finance Lease Liability Undiscounted Excess Amount Year Two FinanceLeaseLiabilityUndiscountedExcessAmountYearTwo	97612	usd
CY2023Q4	guer	Finance Lease Liability Undiscounted Excess Amount Year Three FinanceLeaseLiabilityUndiscountedExcessAmountYearThree	46269	usd
CY2023Q4	guer	Finance Lease Liability Undiscounted Excess Amount Year Four FinanceLeaseLiabilityUndiscountedExcessAmountYearFour	11256	usd
CY2023Q4	guer	Finance Lease Liability Undiscounted Excess Amount Year Five FinanceLeaseLiabilityUndiscountedExcessAmountYearFive	3787	usd
CY2023Q4	guer	Finance Lease Liability Undiscounted Excess Amount After Year Five FinanceLeaseLiabilityUndiscountedExcessAmountAfterYearFive	144	usd
CY2023Q1	guer	Lessee Operating Lease Lease Not Yet Commenced Annual Lease Expense LesseeOperatingLeaseLeaseNotYetCommencedAnnualLeaseExpense	1500000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q4	guer	Deferred Tax Assets Accounts Payable DeferredTaxAssetsAccountsPayable	451478	usd
CY2022Q4	guer	Deferred Tax Assets Accounts Payable DeferredTaxAssetsAccountsPayable	461253	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	5489	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	39598	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	204988	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	112336	usd
CY2023Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	6437	usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	5856	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5633582	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3994815	usd
CY2023Q4	guer	Deferred Tax Assets Nel Carryforwards DeferredTaxAssetsNelCarryforwards	194262	usd
CY2022Q4	guer	Deferred Tax Assets Nel Carryforwards DeferredTaxAssetsNelCarryforwards	239315	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	858020	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	626347	usd
CY2023Q4	guer	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	1590439	usd
CY2022Q4	guer	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	48594	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	34890	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2023Q4	guer	Deferred Tax Assets Capitalized Research And Development Expense DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense	3335888	usd
CY2022Q4	guer	Deferred Tax Assets Capitalized Research And Development Expense DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense	1639623	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12315473	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7167737	usd
CY2023Q4	guer	Deferred Tax Liabilities Trade Receivables And Prepaid Expenses DeferredTaxLiabilitiesTradeReceivablesAndPrepaidExpenses	500514	usd
CY2022Q4	guer	Deferred Tax Liabilities Trade Receivables And Prepaid Expenses DeferredTaxLiabilitiesTradeReceivablesAndPrepaidExpenses	374517	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1579741	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	48171	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2080255	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	422688	usd
CY2023Q4	guer	Deferred Tax Assets Liabilities Before Valuation Allowance DeferredTaxAssetsLiabilitiesBeforeValuationAllowance	10235218	usd
CY2022Q4	guer	Deferred Tax Assets Liabilities Before Valuation Allowance DeferredTaxAssetsLiabilitiesBeforeValuationAllowance	6745049	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10235218	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6745049	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.02	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.016	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.015	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.022	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.219	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.242	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	378177	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	336383	usd
CY2023	dei	Auditor Name AuditorName	FORVIS, LLP
CY2023	dei	Auditor Location AuditorLocation	Raleigh, NC
CY2023	dei	Auditor Firm AuditorFirmId	57

Files In Submission

Name	View Source	Status
0001437749-24-010107-index-headers.html	Edgar Link	pending
0001437749-24-010107-index.html	Edgar Link	pending
0001437749-24-010107.txt	Edgar Link	pending
0001437749-24-010107-xbrl.zip	Edgar Link	pending
ex_602334.htm	Edgar Link	pending
ex_602335.htm	Edgar Link	pending
ex_602336.htm	Edgar Link	pending
ex_602337.htm	Edgar Link	pending
ex_602338.htm	Edgar Link	pending
ex_632180.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
guer-20231231.xsd	Edgar Link	pending
guer20231231_10k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
guer-20231231_def.xml	Edgar Link	unprocessable
guer-20231231_cal.xml	Edgar Link	unprocessable
guer-20231231_lab.xml	Edgar Link	unprocessable
guer-20231231_pre.xml	Edgar Link	unprocessable
guer20231231_10k_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GUER
Guerrilla RF Inc Stock $guer

2024 Q1 Form 10-K Financial Statement

#000143774924010107 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER Guerrilla RF Inc Stock $guer

2024 Q1 Form 10-K Financial Statement

#000143774924010107 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER
Guerrilla RF Inc Stock $guer